Kazakhstan vs SEAR: Estimated antiretroviral therapy coverage among children
Kazakhstan
76
in 2025
SEAR
11
in 2025
Kazakhstan rank
8th
SEAR rank
12th
Estimated antiretroviral therapy coverage among children over time
- Kazakhstan
- SEAR
How they compare
Kazakhstan currently reports 76 against 11 in SEAR, a difference of 65.
That makes Kazakhstan's figure about 6.9 times SEAR's.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was SEAR ahead.
Kazakhstan ranks 8th and SEAR ranks 12th of 89 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | SEAR | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.7 | 2.5 | 13.2 | Kazakhstan |
| 2010s | 77.5 | 9.2 | 68.3 | Kazakhstan |
| 2020s | 71.83 | 11.17 | 60.67 | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among children, Kazakhstan or SEAR?
- Kazakhstan, at 76 against 11 in SEAR as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among children between Kazakhstan and SEAR?
- 65, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and SEAR?
- 26 years are reported by both, from 2000 to 2025.
- How do Kazakhstan and SEAR rank globally for estimated antiretroviral therapy coverage among children?
- Kazakhstan ranks 8th and SEAR ranks 12th of 89 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among children. Statizoid refreshes it automatically from the source and publishes the full history for both places.